Trump Administration strips FDA DEI Health initiatives, harming clinical research and patient care
The pages included draft guidance on clinical trial diversity, a discussion paper about diversity in clinical trials from the Center for Devices and Radiological Health and the equity initiative at the Oncology Center of Excellence, which is responsible for cancer medicines.